Four candidate antibodies, i.e., anti-EpCAM, anti-ASGPR1, anti-CD147, and anti-GPC-3, against the corresponding surface markers were selected to achieve desired sensitivity and specificity for recognizing and capturing HCC EVs. Here, ASGR1 is linked to hepatocellular carcinoma.